100%. Everything in this announcement is positive, other than the loss of one patient which is recognised that they had the more aggressive type of MND, AND was on the weakest trial doses the whole time. The Ph1 data showed how well the 10 mg/kg cohort responded to MPL, which of course is what PAA are moving forward with in the OLE & the Ph2.
100%. Everything in this announcement is positive, other than...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.24M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 108108 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 1500 | 1 |
View Market Depth
| Last trade - 09.38am 21/05/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable